Calcium and the damage pathways in muscular dystrophy

Author： Allen David G.   Gervasio Othon L.   Yeung Ella W.   Whitehead Nicholas P.  

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.88, Iss.2, 2010-02, pp. : 83-91

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging drugs for Duchenne muscular dystrophy

By Malik Vinod   Rodino-Klapac Louise R.   Mendell Jerry R  

Expert Opinion on Emerging Drugs, Vol. 17, Iss. 2, 2012-06 ,pp. : 261-277

Informa Healthcare

Access to resources Recommend Favorite

Novel, effective protocol for muscular dystrophy

By  

Inpharma, Vol. 1, Iss. 1399, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Oxandrolone shows benefits in muscular dystrophy

By  

Inpharma, Vol. 1, Iss. 1292, 2001-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Pathophysiology and Therapy of Cardiac Dysfunction in Duchenne Muscular Dystrophy

By Judge Daniel P.   Kass David A.   Thompson W. Reid   Wagner Kathryn R.  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 5, 2011-10 ,pp. : 287-294

Adis International

Access to resources Recommend Favorite

Molecular pathophysiology and targeted therapeutics for muscular dystrophy

By Hoffman E.P.   Dressman D.  

Trends in Pharmacological Sciences, Vol. 22, Iss. 9, 2001-09 ,pp. : 465-470

Elsevier

Access to resources Recommend Favorite